CORK, Ireland - Bristol-Myers Squibb Co., Pfizer Inc. and the Irish government are the initial backers of a new not-for-profit institute at University College Cork (UCC) that aims to establish a pan-European network specializing in conducting clinical trials of products that have received orphan designation. (BioWorld International) Read More
